VisionCare Ophthalmic Technologies Company

VOT develops visual prosthetic devices to improve vision in patients with end-stage age-related macular degeneration.
VisionCare Ophthalmic Technologies, Inc., a Saratoga, CA-based developer of advanced visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD).
VisionCare Ophthalmic Technologies (VisionCare) is a privately held specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders.
Our lead product, the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), is the first FDA-approved implantable medical device demonstrated to improve vision and quality of life in individuals with the most advanced, irreversible form of age-related macular degeneration (AMD) – End-Stage AMD. End-Stage AMD is the leading cause of blindness in older Americans.
The telescope implant is integral to the CentraSightв„ў treatment program which has been developed to help patients follow the necessary steps for proper diagnosis, surgical evaluation, and postoperative care.
Technology: AgeTech - Medical Devices
Industry: AgeTech
Headquarters: Saratoga
Founded Date: 1997
Employees Number: 11-50
Funding Status: undisclosed

Visit Website
Register and Claim Ownership